 Octagam is a human normal immunoglobulin IGIV solution for intravenous administration. Octagam 5 is currently registered in more than 60 countries. This study will evaluate the efficacy, safety and the kinetics of Octagam 10 for replacement therapy in primary immunodeficiency diseases. 